Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 19Lung Neoplasms 16Prostatic Neoplasms 12Colorectal Neoplasms 12Hematologic Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 6Neoplasms 5Neoplasm Metastasis 5Lymphoma 5Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Melanoma 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Fatigue 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Uterine Cervical Neoplasms 2Skin Carcinoma 2Papillomavirus Infections 2Malignant Solid Neoplasm 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphoid System Neoplasm 2Healthy Subject 2Genital Neoplasms, Female 2Gastrointestinal Neoplasms 2

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Induced Peripheral Neuropathy × Educational Status × 1 year × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡